Stay updated on Nivolumab vs. Everolimus in RCC: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs. Everolimus in RCC: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and v3.5.3 was removed, indicating a small update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-05-16T10:19:46.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    This updates the displayed ClinicalTrials.gov site revision/version label from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T05:14:50.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added collaborator Ono Pharmaceutical Co., Ltd.; removed Ono Pharmaceutical Co. Ltd. Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:32:56.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T06:01:56.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:40.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the Notice about lapse in government funding and the previous Revision: v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-11T11:48:11.000Z thumbnail image

Stay in the know with updates to Nivolumab vs. Everolimus in RCC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.